Good morning, Boston. Here are the five most important things you need to know to start your busy Thursday.
Atlas-backed startup shuts down
Three years after emerging from stealth with plans to use RNA to silence disease-causing genes, Atlas Venture spinout Triplet Therapeutics is winding down its operations. Here's why, from Rowan Walrath.
GreenLight layoffs
Rowan also reports that GreenLight Biosciences Holdings Inc. is laying off a quarter of its staff eight months after it went public through…
